Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.370
+0.020 (0.46%)
At close: Aug 5, 2026, 4:00 PM EDT
4.260
-0.110 (-2.52%)
After-hours: Aug 5, 2026, 5:06 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $8.78 million as of August 5, 2026. Its market cap has increased by 122.89% in one year.
Market Cap
8.78M
Enterprise Value
-3.16M
1-Year Change
122.89%
Ranking
Category
Stock Price
$4.37
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $8.78M, a decrease of -90.97%. That is a compound annual growth rate of -39.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 8.78M | -27.50% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 9.82M |
| IN8bio | 9.45M |
| Lexaria Bioscience | 9.29M |
| Curis | 9.20M |
| Aspire Biopharma Holdings | 9.12M |
| Traws Pharma | 8.38M |
| Immuron | 8.25M |
| Adial Pharmaceuticals | 8.15M |